SSI Investment Management’s Sarepta Therapeutics SRPT Stock Holding History

SSI Investment Management’s Portfolio SRPT Stock Details SRPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-1,437	Closed	-$247K	–	310
2020 Q4	$247K	Sell	1,437 -2	-0.1%	-$296	0.02%	247
2020 Q3	$204K	Sell	1,439 -40	-3%	-$6.08K	0.02%	249
2020 Q2	$237K	Buy	+1,479	New	+$201K	0.02%	233
2020 Q1	–	Sell	-1,549	Closed	-$201K	–	264
2019 Q4	$201K	Buy	+1,549	New	+$156K	0.01%	286
2019 Q3	–	Sell	-1,556	Closed	-$237K	–	294
2019 Q2	$237K	Buy	+1,556	New	+$189K	0.02%	261
2013 Q4	–	Sell	-18,741	Closed	-$884K	–	429
2013 Q3	$884K	Buy	18,741 +2,994	+19%	+$115K	0.08%	226
2013 Q2	$598K	Buy	+15,747	New	+$563K	0.06%	283

Other funds holding SRPT

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

SSI Investment Management's SRPT Position: Q1 2021 in Review

SSI Investment Management sold out of Sarepta Therapeutics (SRPT) in Q1 2021, closing a stake of 1,437 shares — an estimated $247K sold.

SSI Investment Management first reported a position in SRPT in Q2 2013 and held it in 7 quarters. The position peaked at $884K in Q3 2013. 366 funds tracked by Wall St. Rank hold SRPT as of Q1 2021.

SSI Investment Management reported no remaining Sarepta Therapeutics position as of Q1 2021 after selling out during the quarter.
SSI Investment Management sold 1,437 Sarepta Therapeutics shares in Q1 2021, an estimated $247K.
SSI Investment Management first reported a position in Sarepta Therapeutics in Q2 2013 and held it in 7 quarters.
SSI Investment Management's Sarepta Therapeutics position peaked at $884K in Q3 2013.
366 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2021.

Based on SSI Investment Management's 13F filing for Q1 2021, filed 28 May 2021.